Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ · Healthcare
Ionis Pharmaceuticals, Inc. Long Term Debt 2008–2025
Ionis Pharmaceuticals, Inc. annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Ionis Pharmaceuticals, Inc. long term debt for the quarter ending December 31, 2025 were 1.81B, a 44.64% increase year-over-year.
- Ionis Pharmaceuticals, Inc. long term debt for 2025 were 1.81B, a 44.64% increase from 2024.
- Ionis Pharmaceuticals, Inc. long term debt for 2024 were 1.25B, a 4.23% decrease from 2023.
- Ionis Pharmaceuticals, Inc. long term debt for 2023 were 1.31B, a 9.56% increase from 2022.
- Ionis Pharmaceuticals, Inc. long term debt for 2022 were 1.19B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Ionis Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1,812 |
| 2024 | $1,253 |
| 2023 | $1,308 |
| 2022 | $1,194 |
| Ionis Pharmaceuticals, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $1,812 |
| 2024-12-31 | $1,253 |
| 2023-12-31 | $1,308 |
| 2022-12-31 | $1,194 |
Ionis Pharmaceuticals, Inc. Long Term Debt — FAQ
Ionis Pharmaceuticals, Inc. (IONS) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IONS's long term debt history?
The chart and table above show Ionis Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.